Susquehanna International Group, LLP Graybug Vision, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.76 - $1.25 $27,360 - $45,000	-36,000 Reduced 49.93%	36,100 $39,000
Q1 2022 May 16, 2022	SELL	$1.13 - $1.93 $37,855 - $64,655	-33,500 Reduced 31.72%	72,100 $89,000
Q4 2021 Feb 14, 2022	SELL	$1.74 - $3.6 $870 - $1,800	-500 Reduced 0.47%	105,600 $193,000
Q3 2021 Nov 15, 2021	BUY	$3.18 - $5.17 $76,002 - $123,563	23,900 Added 29.08%	106,100 $352,000
Q2 2021 Aug 11, 2021	BUY	$3.53 - $6.1 $290,166 - $501,419	82,200 New	82,200 $446,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.